YOLFTbeta
Oncopeptides AB

Oncopeptides AB

ONCO · ST · Healthcare / Biotechnology

1.77SEK+0.02 (+1.14%)

Price History

Full chart

Market Stats

Previous Close1.75
Open1.75
Day Range1.73 – 1.83
52-Week Range1.26 – 6.35
Volume3.20M
Market Cap803.14M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.73
Dividend Yield0.00%
Beta-1.31
50-Day Avg1.81
200-Day Avg2.04

About

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for with an alkylating payload, developed for the treatment of adult patients with multiple myeloma. The company's PDC platform designed with two components, peptide carrier and a cytotoxic payload which utilizes the altered metabolism of cancer cells to hydrolyze PDC into active hydrophilic metabolites, which lead to an enrichment in cancer cells. It offers OPD5, OPDC3, and Gliopep for the treatment of hematological or solid tumors, and glioblastoma. The company also provides Small Polypeptide based Killer Engagers (SPiKE) platform that is designed to bind to both NK-cells and specific targets on various cancer cells. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Sofia Heigis M.Sc.
  • Employees69
  • HeadquartersLuntmakargatan 46, Stockholm, Sweden, 111 37, Sweden
  • Websitehttps://www.oncopeptides.com/sv

Leadership

  • Ms. Sofia Heigis M.Sc.Chief Executive Officer · b. 1980
  • Prof. Rolf Larsson M.D., Ph.D.Founder
  • Prof. Rolf Lewensohn M.D., Ph.D.Founder
  • Dr. Joachim Gullbo M.D., MSc Pharm, Ph.D.Founder
  • Dr. Kristina Luthman Ph.D.Founder
  • Prof. Hans Ehrsson M.D.Founder
  • Mr. Peter NygrenFounder · b. 1959
  • Mr. Henrik BergentoftChief Financial Officer · b. 1974
  • Ms. Eva Nordström M.Sc., MSc PharmCOO & Deputy MD · b. 1970
  • Mr. David AugustssonDirector of IR, Communications & Corporate Affairs · b. 1984

Financials

Income Statement

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue00000019.36M118.30M8.36M35.22M31.65M71.12M
Growth (%)-------+511.19%-92.94%+321.54%-10.14%+124.72%
Cost of Revenue047.68M24.07K271.00K345.00K4.54M14.40M53.12M6.00K-1.08M2.66M12.12M
Gross Profit0-47.68M-24.07K-271.00K-345.00K-4.54M-14.40M65.17M8.35M36.30M28.98M59.00M
Gross Margin-------74.41%55.09%99.93%103.06%91.59%82.96%
Operating Expense33.11M5.67M114.46M247.35M418.95M734.85M1.58B1.49B357.70M289.75M312.48M284.89M
Operating Income-33.11M-53.35M-114.48M-247.62M-419.30M-739.39M-1.59B-1.42B-349.35M-253.45M-283.50M-225.89M
Operating Margin-------8221.54%-1201.16%-4181.33%-719.61%-895.78%-317.62%
EBITDA-33.09M-53.34M-114.42M-247.35M-419.79M-734.85M-1.58B-1.40B-319.62M-231.62M-261.81M-219.26M
EBITDA Margin-------8145.46%-1182.69%-3825.43%-657.64%-827.24%-308.30%
Net Income-33.09M-53.34M-114.45M-247.62M-419.45M-740.71M-1.59B-1.43B-337.95M-249.11M-284.61M-249.59M
Net Income Margin-------8239.18%-1209.11%-4044.90%-707.30%-899.29%-350.94%
R&D28.07M43.84M89.72M197.77M322.05M548.27M866.21M679.93M217.66M106.95M121.19M99.81M
R&D as % of Total Revenue------4475.40%574.77%2605.11%303.66%382.92%140.35%
Interest Expense4321.00K30502.00K528.00K1.49M948.00K883.00K5.79M12.66M14.45M
Interest Expense % of Total Revenue------7.67%0.80%10.57%16.43%40.00%20.32%

Balance Sheet

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets13.12M4.40M55.63M479.82M444.53M993.49M946.76M439.38M385.32M238.38M244.19M134.84M
Total Liabilities5.52M7.00M29.30M61.82M128.70M196.47M369.86M228.51M91.03M181.60M189.91M193.73M
Total Equity7.61M-2.60M26.34M418.00M315.83M797.01M576.90M210.87M294.29M56.78M54.28M-58.89M
Cash11.97M2.29M40.25M404.05M375.62M926.19M840.25M362.19M344.51M173.41M178.54M82.25M
Total Debt-----6.65M19.36M14.19M9.54M126.16M141.72M139.39M
Net Debt-11.97M-2.29M-40.25M-404.05M-375.62M-919.53M-820.90M-347.99M-334.97M-47.25M-36.82M57.13M

Cash Flow

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-31.44M-52.81M-104.26M-271.50M-333.73M-690.57M-1.30B-1.52B-420.51M-279.49M-260.57M-222.88M
Investing Cash Flow-1.12M-1.12M-1.12M-1.47M-907.00K-2.63M-20.13M-339.00K-2.51M-116.00K496.00K0
Financing Cash Flow35.59M43.14M143.30M636.76M304.89M1.24B1.32B1.03B392.40M106.89M263.81M128.55M
Capital Expenditure1.12M1.12M1.12M1.47M369.00K2.63M17.18M339.00K2.51M116.00K357.00K0
Free Cash Flow-31.44M-52.81M-105.38M-272.97M-334.10M-693.19M-1.31B-1.52B-423.02M-279.61M-260.57M-222.88M
Dividends Paid-----76.59M85.23M82.46M43.21M---
FCF to OCF100.00%100.00%101.07%100.54%100.11%100.38%101.33%100.02%100.60%100.04%100.00%100.00%
Dividend Paid to FCF------11.05%-6.49%-5.44%-10.21%---

Earnings

Report DateMay 18, 2017Aug 25, 2017Nov 15, 2017Feb 22, 2018May 17, 2018Jul 13, 2018Oct 26, 2018Feb 22, 2019May 21, 2019Aug 28, 2019Nov 19, 2019Feb 20, 2020May 26, 2020Aug 26, 2020Nov 19, 2020Feb 18, 2021May 26, 2021Aug 19, 2021Nov 24, 2021Feb 17, 2022May 4, 2022Aug 11, 2022Nov 9, 2022Feb 16, 2023May 4, 2023Aug 10, 2023Nov 8, 2023Feb 27, 2024May 30, 2024Aug 14, 2024Nov 7, 2024Feb 27, 2025May 15, 2025Aug 21, 2025Nov 5, 2025Feb 20, 2026May 13, 2026Aug 27, 2026Nov 5, 2026
EPS Estimate------1.90-1.90-2.20--2.60-3.02-3.61-4.00-5.26-6.06-6.22-6.62-4.85-4.48-3.10-2.15-0.87-0.72-----0.72-0.51----------
EPS Actual-1.60-1.69-1.30-1.68-1.42-3.27-2.34-2.53-2.57-3.52-3.53-4.42-5.37-6.79-5.71-7.59-3.45-4.60-10.33-5.23-1.31-0.79-1.00-1.01-0.79-0.62-0.45-1.00-0.71-0.35-0.29-0.39-0.29-0.30-0.24-0.24-0.12-0.14-
Surprise------72.11%-23.16%-15.00%--35.38%-16.89%-22.44%-34.25%-29.09%5.78%-22.03%47.89%5.15%-130.58%-68.71%39.07%9.20%-38.89%-----38.89%-39.22%----------
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap803.14M
Enterprise Value905.78M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.44
Price / Book37.24
EPS-0.73
Book Value0.063
Revenue (TTM)95.15M
Gross Profit (TTM)91.73M
EBITDA-193.59M
Profit Margin-223.82%
Operating Margin-156.49%
Return on Equity-623.33%
Return on Assets-68.27%
Shares Outstanding381.36M
Shares Float379.39M
Beta-1.31
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 25, 20263047:2875
  • Aug 27, 2025645:608
  • Apr 16, 20243400:2423